Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-09

Clinical Trial Update: The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating the potential effects and mechanisms of flax lignans on type 2 diabetes mellitus, with observations on cho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flax lignans (secoisolariciresinol diglucoside (SDG))

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Type 2 Diabetes, Hypercholesterolemia | Phase 2, Phase 3 | Status: COMPLETED